InflaRx N.V. (IFRX) stock
IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 5/30
$1.11−0.04 (-3.48%)
Close on Nov 18, 2026Market cap $80.25MP/E –Yield –
InflaRx price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
InflaRx's price to sales ratio was 276.6× on Feb 27, 2026.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Feb 27, 2026 | 276.6× | −29.3 |
| 2025 | Dec 31, 2025 | 305.9× | – |
See a number that looks wrong?